A Study to Collect Blood Samples from Patients with Neuromuscular Disorders


About this study

The purpose of this study is to use the candidate gene approach to find the cause of the neuromuscular disease, determine mechanisms by which mutant genes causes the neuromuscular disease, and to use this information to generate structure-function correlations and, if possible, devise strategies for therapy.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Phenotypic criteria pointing to a genetically determined neuromuscular disease.
  • Living and deceased subjects will be included.

Exclusion Criteria:

  • None.



Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Duygu Selcen, M.D.

Open for enrollment

Contact information:

Delana Weis CCRP

(507) 266-7196


More information


Publications are currently not available

Mayo Clinic Footer